July 9, 2020         
Young Canadians and Diverse Communities Among the Hardest Hit Financially by COVID-19, TD Survey Shows   •   American Public University System Selects Dr. Wade Dyke as President   •   Paul Quinn College, Minerva Project Announce Urban Scholars Program Launching Fall 2020   •   ATWEC Technologies Begins Shipping Patented KV-4™ Systems   •   Parks Associates: Households with Children Dominate Consumer Tech Purchases   •   The Word Woman LLC Celebrates 10 Years Serving the Nonprofit Sector   •   T-Mobile Expands Home Internet Pilot in Grand Rapids   •   Women Business Collaborative Focuses on Action with Two New Board Appointments   •   “TYLER PERRY’S MADEA’S FAREWELL PLAY” Set to Launch on BET+ August 27   •   The Meet Group Announces Safer Dating Advisory Board   •   PCS Retirement launches PCS Community Cares Fund   •   McShane Construction Company Underway with Senior Living Residence in Algonquin, Illinois   •   Celebrity Stylist Tara Swennen and Glamhive Founder Stephanie Sprangers Once Again Bring Together Some of the Biggest Names from   •   Survey finds K-12 educators rate open educational resources as equal to offerings from commercial publishers   •   Washington Prime Group Properties Honor Class of 2020 Through Creative #ScholarSpree Campaign   •   Millions of Likee Users Show Support for Black Lives Matter Movement   •   Why Some Experts Predict Potential Rise of ‘Ghost’ Tax Preparers   •   Uniesse Marine Group Launches New Exuma HTC5 Yacht Series   •   Popshop Live to Launch Livestreaming Shopping Platform, Offering an Interactive Solution in Rapidly Changing Post-Pandemic Retai   •   Tampax Partners With Amy Schumer to Turn Your Question Marks Into Periods
Bookmark and Share

RGENIX Shows Clinical Activity of Novel Agent RGX-202 in Patients with KRAS Mutant Colorectal Cancer in Phase 1 Trial

NEW YORK , May 29 /Businesswire/ - Today @RGENIX, a clinical stage biopharma developing first-in-class small molecule and antibody cancer therapeutics, presented data at #ASCO20 showing clinical activity in patients with advanced KRAS mutant colorectal cancer with novel RGX-202 compound.

STORY TAGS: New York, United States, North America, Conference, Trade Show, Product/Service, FDA, Radiology, Pharmaceutical, Oncology, Women, Seniors, Genetics, Men, Clinical Trials, Science, Biotechnology, Alternative Medicine, Consumer, Health, Research,


White House Live Stream
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News